Sublicensing Royalty. In consideration of the license granted hereunder, MBI shall pay to Licensor, without duplication, in respect of any Licensed Products a royalty of [*]% of Sublicensing Revenue collected or received by MBI until the later of either:
Sublicensing Royalty. (a) In this Section 7.3:
Sublicensing Royalty. In consideration of the right to sublicense to Third Parties granted under this Agreement, Omnimmune shall pay to IGR&D twenty percent (20%) of Sublicense Revenue received in the Territory of the USA and ten percent (10%) of Sublicense Revenue received elsewhere in the Territory. The Sublicense Royalty shall be reduced, but not below fifty percent (50%) of the amount due prior to such reduction, by fifty percent (50%) of any royalty amounts, fees or other like payments payable to Third Parties in respect of patent rights, know how or other proprietary rights or information licensed from such Third Parties that are necessary for use of the Licensed Technology as contemplated in this Agreement.
Sublicensing Royalty. As additional consideration for the license granted herein, LICENSEE shall remit to SYSTEM the greater of (i) [***] of royalty income received by LICENSEE from NET SALES by a sublicensee(s) up to the royalty rate prescribed in paragraph 3.03 above; or (ii) [***] of NET SALES recorded by such sublicensee(s).
Sublicensing Royalty. This Section 3.7 outlines obligations taking effect as of the Execution Date and replaces previous obligations as outlined in the Existing Agreement in respect of that section. Upon the Execution Date, or as soon thereafter as practicable, but no later than thirty (30) days after the Execution Date, TTI shall issue: (a) to UHN a one-time allocation of TTI common shares, in an amount equal to $2,000,000.00 and (b) to HSC, a one-time allocation of TTI common shares in an amount equal to $1,000,000.00 (collectively the “TTI Equity”). The price per share of TTI Equity shall be determined as a volume weighted average price of the TTI common shares on the Toronto Stock Exchange over the fourteen (14) day period preceding the date of issuance. For clarity, this one time allocation of TTI Equity to each of the Institutions shall be non-refundable and non-creditable against future royalties (including the Basic Royalty) or milestones payable under this Agreement.
Sublicensing Royalty. In further consideration of the License, TTI shall pay to Institutions a royalty of twenty percent (20%) on the first $50,000,000CAD of sublicensing revenues (including without limitation, upfront payments, milestones and royalties) collected or received by TTI from non-related, arms length third party sublicensees of Licensed Technology, and fifteen percent (15%) on any sublicensing amounts collected or received by TTI thereafter (the “Sublicensing Royalty”). Notwithstanding the foregoing, the Sublicensing Royalty shall exclude any and all R&D payments, reimbursements, loans and equity investments in TTI (except as contemplated below), but only to the extent such remuneration is a bona fide payment in respect of such matters (and not being made in order to reallocate what is otherwise intended to be upfront payments, milestones and royalties). The value of any equity investments in TTI by a sublicensee in excess of the valuation based upon TTI’s last share transaction with a Third Party (other than an officer, employee or shareholder of TTI), where such Third Party share transaction has a value of more than $100,000 shall, provided that such increase in not otherwise arising from a bona fide increase in the fair market value of such equity investments from the last share transaction, be treated as a Sublicensing Royalty.
Sublicensing Royalty. Tactile shall pay to Sun a sublicensing royalty (“Sublicensing Royalty”) of [***]% of sublicensee’s Net Sales of the Products. Such royalty may be modified as provided in Section 3(d) and Section 5. In addition, Tactile shall pay to Sun [***]% of any one-time or lump sum payments made to Tactile by such Sublicensee attributable to the Products (as reasonably agreed by Tactile and Sun) pursuant to any sublicensing agreement, including but not limited to initiation fees, up-front royalties, option payments, milestones, earn-outs and the like. Tactile and Sun will agree to the value of any non-cash consideration received by Tactile from a third party in lieu of cash as consideration from such third party under a sublicense agreement; provided that if Tactile and Sun cannot agree on such value, they will appoint a mutually acceptable appraiser to value the non-cash consideration. For the avoidance of doubt, Sun will be paid its consideration percentage for any non-cash value received by Tactile in cash paid by Tactile.
Sublicensing Royalty. In partial consideration of the License granted hereunder and subject to the terms and conditions stated herein, until the expiration of the applicable Royalty Term on a country-by-country basis, Dermata shall pay to Licensor a royalty of [***] of any royalty payments received from Sublicensees (the “Sublicense Royalty Payment”); provided, however, that if a Licensed Product is sold by a Sublicensee in a country where there is no Valid Claim, the applicable Sublicense Royalty Payment for such country shall be reduced by [***]. Dermata shall pay all Sublicense Royalty Payments due under this Agreement thirty (30) days after the end of each Royalty Reporting Quarter in which the applicable royalty payment is received by Dermata from a Sublicensee.
Sublicensing Royalty. As additional consideration for the license granted herein, LICENSEE shall remit to SYSTEM [***].
Sublicensing Royalty. In consideration of the license granted under Article 3, NeoRx shall pay to AnorMED, without duplication, in respect of any Licensed Compound and/or Licensed Product:
